Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juliana G Doria

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Expert Opinion on Therapeutic Targets|August 15, 2014
Metabotropic glutamate receptor 5 as a potential therapeutic target in Huntington's diseaseFabiola M Ribeiro, Alison Hamilton, Juliana G Doria, et al.
Molecular Brain|August 21, 2016
Orchestrated activation of mGluR5 and CB1 promotes neuroprotectionEdleusa M L Batista, Juliana G Doria, Talita H Ferreira-Vieira, et al.
Scientific Reports|June 1, 2022
mGluR5 ablation leads to age-related synaptic plasticity impairments and does not improve Huntington's disease phenotypeJessica M de Souza, Talita H Ferreira-Vieira, Esther M A Maciel, et al.
Neurochemistry International|April 2, 2019
Metabotropic glutamate receptor 5 ablation accelerates age-related neurodegeneration and neuroinflammationToniana G Carvalho, Juliana Alves-Silva, Jessica M de Souza, et al.
Journal of Neurochemistry|July 21, 2018
The mGluR5 positive allosteric modulator VU0409551 improves synaptic plasticity and memory of a mouse model of Huntington's diseaseJuliana G Doria, Jessica M de Souza, Flavia R Silva, et al.
Toxicology and Applied Pharmacology|May 3, 2015
Enhancement of endocannabinoid signaling protects against cocaine-induced neurotoxicityLuciano R Vilela, Pedro H Gobira, Thercia G Viana, et al.
Mbio|April 27, 2017
<i>N</i>-Methyl-d-Aspartate (NMDA) Receptor Blockade Prevents Neuronal Death Induced by Zika Virus InfectionVivian V Costa, Juliana L Del Sarto, Rebeca F Rocha, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Opinion on Therapeutic Targets|August 15, 2014
Metabotropic glutamate receptor 5 as a potential therapeutic target in Huntington's diseaseFabiola M Ribeiro, Alison Hamilton, Juliana G Doria, et al.
Molecular Brain|August 21, 2016
Orchestrated activation of mGluR5 and CB1 promotes neuroprotectionEdleusa M L Batista, Juliana G Doria, Talita H Ferreira-Vieira, et al.
Scientific Reports|June 1, 2022
mGluR5 ablation leads to age-related synaptic plasticity impairments and does not improve Huntington's disease phenotypeJessica M de Souza, Talita H Ferreira-Vieira, Esther M A Maciel, et al.
Neurochemistry International|April 2, 2019
Metabotropic glutamate receptor 5 ablation accelerates age-related neurodegeneration and neuroinflammationToniana G Carvalho, Juliana Alves-Silva, Jessica M de Souza, et al.
Journal of Neurochemistry|July 21, 2018
The mGluR5 positive allosteric modulator VU0409551 improves synaptic plasticity and memory of a mouse model of Huntington's diseaseJuliana G Doria, Jessica M de Souza, Flavia R Silva, et al.
Toxicology and Applied Pharmacology|May 3, 2015
Enhancement of endocannabinoid signaling protects against cocaine-induced neurotoxicityLuciano R Vilela, Pedro H Gobira, Thercia G Viana, et al.
Mbio|April 27, 2017
<i>N</i>-Methyl-d-Aspartate (NMDA) Receptor Blockade Prevents Neuronal Death Induced by Zika Virus InfectionVivian V Costa, Juliana L Del Sarto, Rebeca F Rocha, et al.
Pageof 1